Maurer, H M <br/><br/>
The Intergroup Rhabdomyosarcoma Study-II.  [electronic resource] 

 -  Cancer  Mar 1993 
 - 1904-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19930301)71:5<1904::aid-cncr2820710530>3.0.co;2-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Dactinomycin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant<br/>Male<br/>Prognosis<br/>Radiotherapy--adverse effects<br/>Rhabdomyosarcoma--drug therapy<br/>Survival Rate<br/>Vincristine--administration & dosage